[ad_1]
The partnership between Lifeforce and Toku, which utilizes the former’s extensive longevity platform and the latter’s AI retinal scans, creates an innovative healthcare pathway that leverages routine eye exams for comprehensive health assessment. The combination of AI diagnostics with human clinical oversight addresses both technological and emotional needs in healthcare, offering scientific rigor alongside physician-guided support.
Toku’s BioAge retinal scanning technology provides non-invasive biological age estimation and cardiovascular risk scoring, while Lifeforce’s platform offers corresponding diagnostic testing, physician consultations, and personalized health optimization protocols. This end-to-end solution bridges the gap between early detection and actionable interventions. Health-conscious individuals seeking proactive aging management would value the convenience of retinal scans combined with personalized longevity protocols.
This collaboration coincides with Toku’s CLAiR technology progressing through the FDA’s Breakthrough Device designation pathway for more rigorous medical applications.
Image Credit: Lifeforce, Toku
[ad_2]
Source link